A Landmark Update: ASH and ISTH Release First Pediatric VTE Guidelines Since 2018
The International Society on Thrombosis and Haemostasis (ISTH) shared a proud post on X:
”Check it out! The American Society of Hematology (ASH) and ISTH Updated Guidelines on the Treatment of Pediatric VTE are featured in Hematology Advisor. Don’t miss this spotlight on our collaborative effort!
”
Read the full feature here.
‘These evidence-based guidelines are a key resource for clinicians to improve the quality of care for this vulnerable population,” said ASH President Belinda R. Avalos, MD.
ASH and ISTH have jointly published updated clinical guidelines for the management of pediatric venous thromboembolism (VTE), featured in Blood Advances.
These new recommendations reflect the latest evidence since ASH’s last update in 2018.
Developed by a multidisciplinary panel, the guidelines address critical aspects of pediatric VTE care—including decisions about whether to initiate treatment, management of acute thrombosis, and tailoring therapy to specific clinical scenarios.
In total, 16 recommendations were revised, and 4 new ones were introduced.
The updated guidelines represent a significant step forward in standardizing and advancing pediatric thrombosis care globally!
Latest advancements in hematology featured in Hemostasis Today.
-
Feb 26, 2026, 15:24Nancy Shapiro: Excited to See This Publication on Current Landscape of Anticoagulation Stewardship Released
-
Feb 26, 2026, 15:15Ahmed Nasreldein: Stay Current on Key Updates in Ischemic and Hemorrhagic Stroke
-
Feb 26, 2026, 15:15Shannon Farmer: What Happens to Vital Signs Pre and Post 1-Unit and 2-Unit RBC Transfusion?
-
Feb 26, 2026, 15:08Emmanuel J Favaloro: When Is A ‘Subtype’ of VWD Not Really VWD?
-
Feb 26, 2026, 15:03Gregory Piazza: Importance of Recognizing PE As A Wide Spectrum of Presentations and Greater Range of Adverse Outcomes
-
Feb 26, 2026, 14:57Abdulla A. Damluji: Sex As An Effect Measure Modifier Between Frailty and Outcomes in AMI Patients
-
Feb 26, 2026, 14:48Ney Carter Borges: The APERITIF Trial Clarifies Rivaroxaban’s Role in LVT
-
Feb 26, 2026, 14:44Wolfgang Miesbach: Synovitis and Haemophilia in Focus at GTH2026
-
Feb 26, 2026, 14:40Al-Ola Abdallah: How Much Does It Cost to Publish in Hematology and Oncology Journals